Liventa Bioscience and Medline Form Advanced Wound Care Partnership
Placental-based wound coverings to reach VA and other health care providers treating chronic wounds
(February 12, 2014) - Liventa Bioscience (formerly AFCell Medical), the trusted innovator in living donor birth tissues to advance wound care healing, has joined forces with industry leader Medline Industries, Inc. to enter the U.S. wound care market. Read the complete press release.
AFcell Medical Changes Its Name to Liventa Bioscience
West Conshohocken, Pa – February 6, 2014 - AFcell Medical has announced that it will now operate under the name Liventa Bioscience, effective immediately. The new name is a derivation of the words “live” and “placenta” and better reflects the company’s mission to improve the lives of patients through its placental-based advanced biologic tissue forms. Read the complete
Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point–of-Service Orthopedic Care
Portable cold chain logistics allows longer shelf life for live tissue cells
Philadelphia/Lake Forest - February 5, 2014 - Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa’s cell-based, advanced biologics tissue forms. Read the complete press release.
“I’ve had lots of really good clinical experiences with AmnioClear. In the wound arena, we really like to use it because it provides a large amount of collagen and growth factors...”
- Dr. Adam Landsman
Assistant Professor of Surgery, Harvard Medical School
Chief Division of Podiatric
100 Four Falls Corporate Center, Suite 660
1001 Conshohocken State Road
West Conshohocken, PA 19428
©2014 Liventa Bioscience Contact Us: dbuche@LiventaBio.com